Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Oct 17;12(10):880.
doi: 10.3390/bios12100880.

Fundamentals of SARS-CoV-2 Biosensors

Affiliations
Editorial

Fundamentals of SARS-CoV-2 Biosensors

Carlos Torres-Torres et al. Biosensors (Basel). .

Abstract

A beautiful topic in its essence and content is represented by the powerful assistance of sensing methods and techniques for automatically revealing biological agents and biological functions in this era [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

References

    1. Lim W.Y., Lan B.L., Ramakrishnan N. Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review. Biosensors. 2021;11:434. doi: 10.3390/bios11110434. - DOI - PMC - PubMed
    1. Serebrennikova K.V., Byzova N.A., Zherdev A.V., Khlebtsov N.G., Khlebtso B.N., Biketo S.F., Dzantiev B.B. Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays. Biosensors. 2021;11:510. doi: 10.3390/bios11120510. - DOI - PMC - PubMed
    1. Peng T., Jiao X., Liang Z., Zhao H., Zhao Y., Xie J., Jiang Y., Yu X., Fang X., Dai X. Lateral Flow Immunoassay Coupled with Copper Enhancement for Rapid and Sensitive SARS-CoV-2 Nucleocapsid Protein Detection. Biosensors. 2022;12:13. doi: 10.3390/bios12010013. - DOI - PMC - PubMed
    1. Liang Z., Peng T., Jiao X., Zhao Y., Xie J., Jiang Y., Meng B., Fang X., Yu X., Dai X. Latex Microsphere-Based Bicolor Immunochromatography for Qualitative Detection of Neutralizing Antibody against SARS-CoV-2. Biosensors. 2022;12:103. doi: 10.3390/bios12020103. - DOI - PMC - PubMed
    1. Flores-Contreras E.A., González-González R.B., Rodríguez-Sánchez I.P., Yee-de León J.F., Iqbal H.M.N., González-González E. Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence. Biosensors. 2022;12:179. doi: 10.3390/bios12030179. - DOI - PMC - PubMed

Publication types

Substances